The influence of tamoxifen on growth behavior and cell-cell adhesion in OSCC in vitro

Oral Oncology

Volumn 43, Issue 7, 2007, Pages 720-727

  Nelson, Katja ^a   Helmstaedter, Victor ^b   Lage, Herrmann ^b  

^a Clinic for Oral and Maxillofacial Surgery   (Germany)

^b Charité Campus Benjamin Franklin Medical Center   (Germany)

Author keywords

Catenin; E cadherin; Estrogen receptor; OSCC; Tamoxifen

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR; TAMOXIFEN; UVOMORULIN;

ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

BETA CATENIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 34447318656     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.09.005     Document Type: Article

References (34)

1. Nagpal J.K., and Das B.R. Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions of its effective management. Oral Oncol 39 (2003) 213-221
2. Prudencio J., Akutsu N., Benlimame N., Wang T., Bastien Y., Lin R., et al. Action of low calcemic 1-alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer Inst 93 10 (2001) 745-753
3. Cohen E.E.W. Novel therapeutic targets in squamous cell carcinoma of the head and neck. Semin Oncol 31 6 (2004) 755-768
4. Wijnhoven B.P.L., Dinjens W.N.M., and Pignatelli M. E-cadherin/catenin cell-cell adhesion complex and human cancer. Br J Surg 87 8 (2000) 992-1005
5. Vermeulen S.J., Bruyneel E.A., Roy F.M., Mareel M.M., and Bracke M.E. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br J Cancer 72 6 (1995) 1447-1453
6. Behrens J. Control of beta-catenin signaling in tumor development. Ann NY Acad Sci 910 (2000) 21-33
7. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metast Rev 18 1 (1999) 15-30
8. Barker N., and Clevers H. Catenins, Wnt signaling and cancer. Bio Essays 22 11 (2000) 961-965
9. Nelson W.J., and Nusse R. Convergence of Wnt, β-catenin, and cadherin pathway. Science 303 5663 (2004) 1483-1487
10. Diniz-Freitas M., Garcia-Caballero T., Antúnez-López J., Gándara-Rey J.M., and Garciá-Garcia A. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42 2 (2006) 190-200
11. Ueda G., Sunakawa H., Nakamori K., Shinya T., Tsuhako W., Tamura Y., et al. Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma. J Oral Maxillofac Surg 35 4 (2006) 356-361
12. Bracke M.E., Vyncke B.M., Bruyneel E.A., Vermeulen S.J., Bruyne G.K.D., Larebeke N.A.V., et al. Insulin-like growth factor I activates the invasion suppressor function of E-cadherin in MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 68 2 (1993) 282-289
13. Osborne C.K., and Fuqua S.A.W. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 18 17 (2000) 3172-3186
14. Atallah E., and Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 6 3 (2005) 185-193
15. Hui A.M., Zhang W., Chen W., Xi D., Purow B., Friedman G.C., et al. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro an in vivo in ER-negative glioma cells. Cancer Res 64 24 (2004) 9115-9123
16. Yang C.H., Cheng A.L., Yeh K.H., Yu C.J., Lin J.F., and Yang P.C. High dose Tamoxifen plus Cisplatin and etoposide in the treatment of patients with advanced, inoperable non-small cell lung carcinoma. Cancer 86 3 (1999) 415-420
17. Tavassoli M., Soltaninia J., Rudnicka J., Mashanyare D., Johnson N., and Gaken J. Tamoxifen inhibits the growth of head and neck cancer cells and sensitizes these cells to cisplatin induced-apoptosis: role of TGF-beta1. Carcinogenesis 23 10 (2002) 1569-1575
18. Kim MJ, Lee JH, Kim YK, Myoung H, Yun PY. The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines. Cancer Lett 2006; Feb 28: [Epub ahead of print].
19. In: Masters J.R.W. (Ed). BP. Human cell culture vol. 2 (1999), Kluwer Academic Publishers, Dordrecht p. 185-255
20. Brooks S.A., and Schumacher U. Metastasis research protocols vol. 2 (2001), Humanae Press, Clifton, UK p. 33-44
21. Wichert A., Stege A., Midorikawa Y., Holm P.S., and Lage H. Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells. Oncogene 23 4 (2004) 945-955
22. Lage H. Molecular analysis of therapy resistance in gastric cancer. Digest Dis 21 4 (2003) 326-338
23. Shapira A., Virolainen E., Jameson J.J., et al. Growth inhibition of laryngeal UM-SCC cell lines by Tamoxifen, comparison with effects on the MCF-7 breast cancer cell line. Arch Otolaryngol Head Neck Surg 112 11 (1986) 1157-1158
24. Cavallaro U., and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4 2 (2004) 1130-1132
25. Hoffmann T.K., Bojar H., Eckel J., van Lierop A., Balz V., Friebe-Hoffmann U., Hauser U., and Bier H. Effects of tamoxifen on human squamous cell carcinoma lines of the head and neck. Anticancer Drugs 13 5 (2002) 521-531
26. Kim Y.J., Lee C.J., Lee U., and Yoo Y.M. Tamoxifen-induced cell death and expression of neurotrophic factors in cultured C6 glioma cells. J Neuro Oncol 71 (2005) 121-125
27. Kudo Y., Kitajima S., Ogawa I., Hiraoka M., Sargolzaei S., Keikhaee M.R., et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous β-catenin. Clin Cancer Res 10 16 (2004) 5455-5463
28. Chen Q., Lipkina G., Song Q., and Kramer R.H. Promoter methylation regulates cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun 315 4 (2004) 850-856
29. Auerkari E.I. Methylation of tumor suppressor gene p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42 1 (2006) 5-13
30. Fearon E. connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell 3 4 (2003) 307-310
31. Tamura I., Sakaki T., Chaqour B., Howard P.S., Ikeo T., and Macarak E. Correlation of P-cadherin and beta-catenin expression and phosphorylation with carcinogenesis in rat tongue cancer induced with 4-nitroquinoline 1-oxide. Oral Oncol 39 5 (2003) 506-514
32. Scully C., Bagan J.-V., Black M., Carrozzo M., Eisen D., Escudier M., et al. Mucosal disease series. Number I: epithelial biology. Oral Dis 11 2 (2005) 58-71
33. Kantak S.S., and Kramer R.H. E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 273 27 (1998) 16953-16961
34. ctn. Oncogene 25 33 (2006) 4595-4604